Eye and Ear study supports safety and efficacy of implanting hearing devices after cancer

AI generated image generated from an original photo of a cancer patient with a cochlear implant button processor. Image: Jean-Marc Gerard and ChatGPT. A new Melbourne study supports the safety and effectiveness of implantable hearing devices in patients after head and neck cancer treatment, says corresponding author, ENT surgeon Associate Professor JEAN-MARC GERARD....

Continue reading at Hearing Practitioner Australia →

This study provides early evidence that implantable hearing devices are a viable option for head and neck cancer survivors; audiologists managing this population should be aware of the emerging evidence, though case volume and study design details should be reviewed before changing referral or candidacy protocols.

Head and neck cancer treatment frequently causes significant hearing loss, and this study begins to establish an evidence base for implantable hearing rehabilitation in a population historically considered high-risk for surgical intervention.

1. 01Melbourne Eye and Ear Hospital study assessed implantable hearing devices in head and neck cancer survivors.
2. 02Findings support both safety and efficacy of implantation in this post-cancer population.
3. 03Head and neck cancer treatment (e.g., radiotherapy) often damages hearing structures, creating high rehabilitation need.
4. 04This is a single-centre study, limiting generalisability without knowing sample size and design details.
5. 05Results may expand candidacy criteria for implantable devices to include post-oncology patients.

Publication type

research_article

Evidence level

4

Population

Patients with hearing loss who have undergone treatment for head and neck cancer

Intervention

Implantable hearing devices (e.g., cochlear implants or bone-anchored hearing devices) in post-head-and-neck-cancer patients